Abstract:Pulmonary senescence is accelerated by unresolved DNA damage response, underpinning susceptibility to pulmonary fibrosis. Recently it was reported that the SARS-Cov-2 viral infection induces acute pulmonary epithelial senescence followed by fibrosis, although the mechanism remains unclear. Here, we examine roles of alveolar epithelial stem cell senescence and senescence-associated differentiation disorders in pulmonary fibrosis, exploring the mechanisms mediating and preventing pulmonary fibrogenic crisis. Notably, the TGF-β signalling pathway mediates alveolar epithelial stem cell senescence by mechanisms involving suppression of the telomerase reverse transcriptase gene in pulmonary fibrosis. Alternatively, telomere uncapping caused by stress-induced telomeric shelterin protein TPP1 degradation mediates DNA damage response, pulmonary senescence and fibrosis. However, targeted intervention of cellular senescence disrupts pulmonary remodelling and fibrosis by clearing senescent cells using senolytics or preventing senescence using telomere dysfunction inhibitor (TELODIN). Studies indicate that the development of senescence-associated differentiation disorders is reprogrammable and reversible by inhibiting stem cell replicative senescence in pulmonary fibrosis, providing a framework for targeted intervention of the molecular mechanisms of alveolar stem cell senescence and pulmonary fibrosis. Abbreviations: DPS, developmental programmed senescence; IPF, idiopathic pulmonary fibrosis; OIS, oncogene-induced replicative senescence; SADD, senescence-associated differentiation disorder; SALI, senescence-associated low-grade inflammation; SIPS, stress-induced premature senescence; TERC, telomerase RNA component; TERT, telomerase reverse transcriptase; TIFs, telomere dysfunction-induced foci; TIS, therapy-induced senescence; VIS, virus-induced senescence.

Age-Dependent Inflammatory Microenvironment Mediates Alveolar Regeneration

Aged alveolar epithelium contributes to inflammaging and reduced stem cell function in the lung

Inflamm-Aging-Related Cytokines of IL-17 and IFN- Accelerate Osteoclastogenesis and Periodontal Destruction

Aging-Associated Molecular Changes in Human Alveolar Type I Cells

Transcriptomics Analysis Identifies the Decline in the Alveolar Type II Stem Cell Niche in Aged Human Lungs

Senescence in Alveolar Epithelial Type II Cells Promotes Acute Lung Injury and Impairs Regeneration

Single-cell RNA sequencing profiling of the effects of aging on alveolar stem cells

Prolonged WNT/ß-catenin signaling induces cellular senescence in aging and pulmonary fibrosis

Role of Cellular Senescence in Inflammatory Lung Diseases

Intersection of Inflammation and Senescence in the Aging Lung Stem Cell Niche

Enhanced glycolysis-mediated energy production in alveolar stem cells is required for alveolar regeneration

An Atlas of the Aging Lung Mapped by Single Cell Transcriptomics and Deep Tissue Proteomics

The Aging Microenvironment Shapes Alveolar Macrophage Identity in Aging

Aging and senescence in alveolar epithelial type II cells affect progenitor cell function and aggravate acute lung injury

Aging affects reprogramming of pulmonary capillary endothelial cells after lung injury

Zom-biecoming: Single-Cell RNA-sequencing reveals senescence-like features of alveolar macrophages during aging

Cell Cross-Talk in Alveolar Microenvironment: From Lung Injury to Fibrosis

Impact of Aging on Repair Capability of Lung Stem Cells in a Mouse Model of Pulmonary Fibrosis

Molecular Mechanisms of Alveolar Epithelial Stem Cell Senescence and Senescence-Associated Differentiation Disorders in Pulmonary Fibrosis

Molecular programs of fibrotic change in aging human lung

[Research Progress of Lung Aging in Chronic Respiratory Diseases].